Guardion Health Sciences, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Guardion Health Sciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q2 2024.
  • Guardion Health Sciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 53 %, a 14% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 53 -8.62 -14% Jun 30, 2024
Q1 2024 83.7 +34.7 +70.9% Mar 31, 2024
Q4 2023 66.9 +14.3 +27.2% Dec 31, 2023
Q3 2023 82.5 +47.7 +137% Sep 30, 2023
Q2 2023 61.6 +37.2 +152% Jun 30, 2023
Q1 2023 49 +33.2 +210% Mar 31, 2023
Q4 2022 52.6 +48.1 +1077% Dec 31, 2022
Q3 2022 34.8 +29.7 +583% Sep 30, 2022
Q2 2022 24.4 +18.5 +313% Jun 30, 2022
Q1 2022 15.8 +8.68 +122% Mar 31, 2022
Q4 2021 4.47 -8.02 -64.2% Dec 31, 2021
Q3 2021 5.1 -5.48 -51.8% Sep 30, 2021
Q2 2021 5.9 -4.06 -40.8% Jun 30, 2021
Q1 2021 7.12 -4.06 -36.3% Mar 31, 2021
Q4 2020 12.5 -5.69 -31.3% Dec 31, 2020
Q3 2020 10.6 -14.7 -58.1% Sep 30, 2020
Q2 2020 9.96 Jun 30, 2020
Q1 2020 11.2 Mar 31, 2020
Q4 2019 18.2 Dec 31, 2019
Q3 2019 25.2 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.